Prophylactic Fibrinogen Reduces Excessive Bleeding in Total Hip Arthroplasty Surgery: A Randomized Double-blinded Placebo-controlled Trial

Document Type : LETTER TO THE EDITOR

Authors

1 Department of Orthopedic Surgery, Hualien Armed Forces General Hospital, Taiwan/Department of Orthopedic Surgery, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan

2 Department of anesthesiology, Shahid Beheshti University of Medical Science, Tehran, Iran

3 Clinical Research and Development Unit, Department of Anesthesiology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

We read with interest the article titled "Prophylactic Fibrinogen Reduces Excessive Bleeding in Total Hip Arthroplasty Surgery: A Randomized Double-blinded Placebo-controlled Trial" authored by Alireza Shakeri et al. with great interest. We commend the authors for their efforts to demonstrate the hemostatic effect of fibrinogen in total hip arthroplasty. However, we are concerned about the lack of clear criteria for postoperative blood transfusion in patients undergoing total hip arthroplasty, a crucial aspect that significantly influences the methodology of this study.

Keywords

Main Subjects

References

1. Iranian National Guideline of Transfusion. Available
at:https://iranesthesia.org/wpcontent/uploads/2016/09/Iranian-National-Guideline-ofTransfusion.pdf, 2016.
The Archives of Bone and Joint Surgery
Volume 11, Issue 11
November 2023
Pages 729-730

Files

History

  • Receive Date: 20 August 2023
  • Revise Date: 30 October 2023
  • Accept Date: 27 September 2023

Share

How to cite

Statistics